Abstract
We have studied the structure and function of Human Misshapen / NIK-related kinase (MINK-1)through a combination of computational methods and experimental approaches,including (1)fold recognition and sequence-structure alignment for each structural domain using the threading program PROSPECT,(2)gene expression and protein-protein interaction analysis of yeast homologs of human MINK-1 domains,and (3)yeast two-hybrid screening for proteins that interact with human MINK-1.Our structure prediction dissects MINK-1 into four domains:a conserved N-terminal kinase domain,followed by a coiled-coil region and a proline-rich region,and a C- terminal GCK domain.Gene expression and yeast two-hybrid analysis of yeast homologs of the MINK-1 domains suggest that MINK-1 may be involved in cell-cycle progression and cytoskeletal control.Consistent with these predicted functions,our in-house yeast two-hybrid screen for proteins that interact with human MINK-1 provides strong evidence that the coiled-coil and proline-rich domains of MINK-1 participate in the regulation of cytoskeletal organization,cell-cycle control and apoptosis.A homology model of the MINK-1 kinase domain was used to screen the NCI open compound database in DOCK,and chemical compounds with pharmaceutically acceptable properties were identified.Further medicinal chemistry compound structure optimization and kinase assays are underway.
Keywords: mink, ste20-related kinases, gck domain, signal transduction, protein structure prediction, threading, yeast two-hybrid, gene expression, docking
Current Medicinal Chemistry
Title: Computational and Experimental Studies on Human Misshapen / NIK- Related Kinase MINK-1
Volume: 11 Issue: 5
Author(s): Kunbin Qu, Yanmei Lu, Nan Lin, Rajinder Singh, Xiang Xu, Donald G. Payan and Dong Xu
Affiliation:
Keywords: mink, ste20-related kinases, gck domain, signal transduction, protein structure prediction, threading, yeast two-hybrid, gene expression, docking
Abstract: We have studied the structure and function of Human Misshapen / NIK-related kinase (MINK-1)through a combination of computational methods and experimental approaches,including (1)fold recognition and sequence-structure alignment for each structural domain using the threading program PROSPECT,(2)gene expression and protein-protein interaction analysis of yeast homologs of human MINK-1 domains,and (3)yeast two-hybrid screening for proteins that interact with human MINK-1.Our structure prediction dissects MINK-1 into four domains:a conserved N-terminal kinase domain,followed by a coiled-coil region and a proline-rich region,and a C- terminal GCK domain.Gene expression and yeast two-hybrid analysis of yeast homologs of the MINK-1 domains suggest that MINK-1 may be involved in cell-cycle progression and cytoskeletal control.Consistent with these predicted functions,our in-house yeast two-hybrid screen for proteins that interact with human MINK-1 provides strong evidence that the coiled-coil and proline-rich domains of MINK-1 participate in the regulation of cytoskeletal organization,cell-cycle control and apoptosis.A homology model of the MINK-1 kinase domain was used to screen the NCI open compound database in DOCK,and chemical compounds with pharmaceutically acceptable properties were identified.Further medicinal chemistry compound structure optimization and kinase assays are underway.
Export Options
About this article
Cite this article as:
Qu Kunbin, Lu Yanmei, Lin Nan, Singh Rajinder, Xu Xiang, Payan G. Donald and Xu Dong, Computational and Experimental Studies on Human Misshapen / NIK- Related Kinase MINK-1, Current Medicinal Chemistry 2004; 11 (5) . https://dx.doi.org/10.2174/0929867043455873
DOI https://dx.doi.org/10.2174/0929867043455873 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Endogenous H2S in Cardiovascular Physiology
Current Pharmaceutical Biotechnology Ribonucleases and ImmunoRNases as Anticancer Drugs
Current Pharmaceutical Design Osteoclast Apoptosis in Rheumatic Diseases Characterized by a High Level of Bone Resorption (Osteoporosis, Rheumatoid Arthritis, Myeloma and Pagets Disease of Bone)
Current Rheumatology Reviews Banking Strategies for Improving the Hematopoietic Stem Cell Content of Umbilical Cord Blood Units for Transplantation
Current Stem Cell Research & Therapy The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection
Current Pharmaceutical Design Versatile Applications of microRNA in Anti-Cancer Drug Discovery: From Therapeutics to Biomarkers
Current Drug Discovery Technologies ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Current Pharmaceutical Design Beyond Photodynamic Therapy: Light-Activated Cancer Chemotherapy
Current Medicinal Chemistry Intracellular Bioinorganic Chemistry and Cross Talk Among Different -Omics
Current Topics in Medicinal Chemistry Azelaic Acid: A Promising Agent for Dermatological Applications
Current Drug Therapy To Cardiovascular Disease and Beyond: New Therapeutic Perspectives of Statins in Autoimmune Diseases and Cancer
Current Drug Targets A Role for Milk Proteins and their Peptides in Cancer Prevention
Current Pharmaceutical Design Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94
Current Topics in Medicinal Chemistry Doxorubicin-Induced In Vivo Nephrotoxicity Involves Oxidative Stress- Mediated Multiple Pro- and Anti-Apoptotic Signaling Pathways
Current Neurovascular Research TRPV1 Function in Health and Disease
Current Pharmaceutical Biotechnology Pulmonary Arterial Hypertension in HIV-infected Patients
Current Hypertension Reviews Development of RGD-Based Radiotracers for Tumor Imaging and Therapy: Translating from Bench to Bedside
Current Molecular Medicine Advances in the Development of Anticancer HSP-based Vaccines
Current Medicinal Chemistry Nuclear Translocation of Heme Oxygenase-1 Confers Resistance to Imatinib in Chronic Myeloid Leukemia Cells
Current Pharmaceutical Design Lipid Nucleoside Conjugates for the Treatment of Cancer
Current Pharmaceutical Design